NDC 51662-1291-2 - DOPAMINE HCI
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51662-1291
- Requested NDC
- 51662-1291-2
- Package NDCs from labels
- 51662-1291-1, 51662-1291-2, 51662-1291-3
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2024-02-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| DOPAMINE HCI - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-02-22 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51662-1291-1 | 2020-02-07 | C162847 | 48780-1 | 9d75b9d0-bbd2-f424-e053-dadaa90a57ce | DOPAMINE HCI INJ., USP 200mg (40 mg/mL) 5mL VIAL |
| 51662-1291-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-bbd2-f424-e053-dadaa90a57ce | DOPAMINE HCI INJ., USP 200mg (40 mg/mL) 5mL VIAL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51662-1291-1 | DOPAMINE HCI | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION, CONCENTRATE | 5 | 7 | |
| 51662-1291-2 | DOPAMINE HCI | 1 in 1 POUCH | INJECTION, SOLUTION, CONCENTRATE | 1 | 7 | |
| 51662-1291-2 | DOPAMINE HCI | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION, CONCENTRATE | 5 | 7 | |
| 51662-1291-3 | DOPAMINE HCI | 25 in 1 CASE | INJECTION, SOLUTION, CONCENTRATE | 25 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51662-1291 | DOPAMINE HCI INJECTION, SOLUTION, CONCENTRATE [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 7 | Current NDC, Legacy NDC, 4 package rows | 20240224_763d2b07-9cea-782e-e053-2a91aa0adc01.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DOPamine Hydrochloride | DOPAMINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | b61fffd0-7bc8-09e2-e053-2995a90ae0e4 | 2023-05-30 | Warnings, Adverse reactions | NDA018132 1743941 7L3E358N9L |
| Neuro T Support Liquescence | ALFALFA, BANANA, VALERIANA OFFICINALIS, CHOLINUM, GABA (GAMMA AMINOBUTYRIC ACID), INOSITOL, OLEANDER, HYPOPHYSIS SUIS, HYPOTHALAMUS SUIS, PINEAL GLAND (SUIS), SCUTELLARIA LATERIFLORA, ACETYLCHOLINE CHLORIDE, NOREPINEPHRINE (BITARTRATE), CADMIUM METALLICUM, DOPAMINE (HYDROCHLORIDE), SEROTONIN (HYDROCHLORIDE), ADRENALINUM | Nutritional Specialties, Inc. | 727f168a-6d9c-4ff5-b161-8bf0642a117b | 2023-04-25 | Warnings | 7L3E358N9L |
| Emetrol Chewables Mixed Berry | SODIUM CITRATE DIHYDRATE | WellSpring Pharmaceutical Corporation | 4965fab0-828d-4f1d-8d43-a636e0a8c1ea | 2023-03-23 | Warnings | B22547B95K |
| Emetrol Chewables Orange | SODIUM CITRATE DIHYDRATE | WellSpring Pharmaceutical Corporation | e9072f9d-d74c-4e43-bcfe-ee005577df35 | 2023-03-23 | Warnings | B22547B95K |
| triCitrasol | TRISODIUM CITRATE DIHYDRATE | Citra Labs LLC | 64e7652c-1437-43bd-8ea2-3cafab447b8c | 2023-02-14 | Warnings, Adverse reactions | B22547B95K |
| Anticoagulant Citrate Dextrose A | ANHYDROUS CITRIC ACID, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Citra Labs LLC | 5bcd261e-ebba-4ecb-af22-e5aaeb04499b | 2023-02-14 | Warnings, Adverse reactions | XF417D3PSL B22547B95K |
| CitriPlus | JUGLANS REGIA WHOLE AND ANHYDROUS CITRIC ACID | PEKANA Natuheilmittel GmbH | 11db1b5b-2959-42c4-a059-25c951933004 | 2023-01-11 | Warnings | XF417D3PSL |
| Hunger Control | ADENOSINUM TRIPHOSPHORICUM DINATRUM, ADRENAL CORTEX (SUIS), BACOPA SPECIOSA, EQUOL, PANTOTHENIC ACID, RHODIOLA, STOMACH (SUIS), CHININUM SULPHURICUM, IODIUM, LYCOPODIUM CLAVATUM, PHOSPHOROUS, DOPAMINE HYDROCHLORIDE, THYROIDINUM (SUIS), CINA, SEROTONIN (HYDROCHLORIDE), OXYTOCIN, GAMBOGIA, MORGAN GAERTNER | Pro Weight Loss Inc. | b5384127-01a6-4cfd-af62-5cd949e61151 | 2023-01-10 | Warnings | 7L3E358N9L |
| Glucoreg | ASCORBICUM ACIDUM, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SARCOLACTICUM ACIDUM, THIAMINUM HYDROCHLORICUM, DHEA (DEHYDROEPIANDROSTERONE), PHLORIDZINUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-LIPOICUM ACIDUM, CITRICUM ACIDUM, FUMARICUM ACIDUM, NADIDUM, PANTOTHENIC ACID, ACETALDEHYDE, INSULINUM (SUIS), INSULINUM (HUMAN), HEPAR SUIS, PANCREAS SUIS, PHLORIDZINUM, BARYTA OXALICA, ALLOXANUM, BERBERIS VULGARIS, CARCINOSIN, LYCOPODIUM CLAVATUM, MOMORDICA BALSAMINA, PHOSPHORICUM ACIDUM, PHOSPHORUS, | Deseret Biologicals, Inc. | 5117f980-95b8-4fc8-9425-8f6f05639437 | 2022-12-29 | Warnings | XF417D3PSL |
| Sodium Citrate Blood-Pack Units, (PL 146 Plastic) | ANTICOAGULANT SODIUM CITRATE SOLUTION | Fenwal, Inc. | 14b238ab-904b-45dc-9eb9-a1074364e089 | 2022-11-07 | B22547B95K | |
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION | Fenwal, Inc. | d55cb701-9664-4931-8754-1a8cae68da06 | 2022-11-01 | XF417D3PSL B22547B95K | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) SOLUTION | Fenwal, Inc. | f9d7f1b4-7a77-44f9-8924-10b16008b49d | 2022-11-01 | XF417D3PSL B22547B95K | |
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) | Fenwal, Inc. | 4a08a9ec-46a5-4fcf-80ee-5c33f1a8b746 | 2022-11-01 | XF417D3PSL B22547B95K | |
| Bio Co-Enzyme Phase | BETA VULGARIS, ASCORBICUM ACIDUM, CYSTEINUM, NATRUM OXALACETICUM, NICOTINAMIDUM, PULSATILLA (PRATENSIS), PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, THIAMINUM HYDROCHLORICUM, ALPHA-KETOGLUTARICUM ACIDUM, ALPHA-LIPOICUM ACIDUM, CERIUM OXALICUM, CITRICUM ACIDUM, FUMARICUM ACIDUM, MAGNESIUM OROTICUM DIHYDRICUM, MALICUM ACIDUM, NADIDUM, NATRUM PYRUVICUM, PANTOTHENIC ACID, SUCCINICUM ACIDUM, ADRENALINUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, HEPAR SULPHURIS CALCAREUM, SULPHUR, ACONITICUM ACIDUM, CIS-, | Deseret Biologicals, Inc. | e8f6e2ec-ae2e-4bee-b9d3-5f3a2e3daf65 | 2022-05-09 | Warnings | XF417D3PSL |
| ACD Blood-Pack Units (PL 146 PLASTIC) | ANTICOAGULANT CITRATE DEXTROSE (ACD) | Fenwal, Inc. | ba894daa-688e-4a9e-bd74-e71797f951bb | 2022-04-27 | XF417D3PSL B22547B95K | |
| Sodium Citrate Blood-Pack Units, (PL 146 Plastic) | ANTICOAGULANT SODIUM CITRATE SOLUTION | Fenwal, Inc. | a63da38d-1fea-4ee0-a70b-55c891a5ebcc | 2022-02-11 | B22547B95K | |
| Sodium Citrate Blood-Pack Units, (PL 146 Plastic) | ANTICOAGULANT SODIUM CITRATE SOLUTION | Fenwal, Inc. | ac8971a9-36d0-43c9-9121-ba5e58c28bed | 2022-02-11 | B22547B95K | |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | Fenwal, Inc. | 22805f0d-ba58-41ea-b245-19980abcda22 | 2022-02-11 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | d763511e-f1a7-4014-94b9-f7ad8f023ff4 | 2021-12-02 | XF417D3PSL B22547B95K | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | cf9f43a0-c750-4cf0-ac49-176ab2105aab | 2021-12-02 | XF417D3PSL B22547B95K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.